Peter P. Wibroe

1.3k total citations
14 papers, 996 citations indexed

About

Peter P. Wibroe is a scholar working on Biomaterials, Molecular Biology and Immunology. According to data from OpenAlex, Peter P. Wibroe has authored 14 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Peter P. Wibroe's work include Nanoparticle-Based Drug Delivery (7 papers), Complement system in diseases (4 papers) and Lipid Membrane Structure and Behavior (3 papers). Peter P. Wibroe is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Complement system in diseases (4 papers) and Lipid Membrane Structure and Behavior (3 papers). Peter P. Wibroe collaborates with scholars based in Denmark, United Kingdom and United States. Peter P. Wibroe's co-authors include S. Moein Moghimi, A. Christy Hunter, Davoud Ahmadvand, Anan Yaghmur, Alina J. Andersen, Thomas L. Andresen, Mohammad Ali Oghabian, Intan Diana Mat Azmi, Linping Wu and Per H. Nilsson and has published in prestigious journals such as Nature Nanotechnology, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Peter P. Wibroe

14 papers receiving 985 citations

Peers

Peter P. Wibroe

BIOMA

IMMUN

Douglas R. Vogus United States

Vinu Krishnan United States

Laura Pandolfi Italy

Diego A. Chiappetta Argentina

Melissa D. Howard United States

Sushilkumar Patil India

Nidhi Raval India

In‐Hyun Lee South Korea

Dipesh Baradia India

Brandon Smith United States

Douglas R. Vogus United States

Peter P. Wibroe

659 ×1.7

BIOMA

491 ×1.4

549 ×1.8

113 ×0.5

IMMUN

105 ×0.6

Citations per year, relative to Peter P. Wibroe Peter P. Wibroe (= 1×) peers Douglas R. Vogus

Countries citing papers authored by Peter P. Wibroe

Since Specialization

Citations

This map shows the geographic impact of Peter P. Wibroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Wibroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Wibroe more than expected).

Fields of papers citing papers by Peter P. Wibroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Wibroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Wibroe. The network helps show where Peter P. Wibroe may publish in the future.

Co-authorship network of co-authors of Peter P. Wibroe

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Wibroe. A scholar is included among the top collaborators of Peter P. Wibroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Wibroe. Peter P. Wibroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wibroe, Peter P., Aaron C. Anselmo, Per H. Nilsson, et al.. (2017). Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nature Nanotechnology. 12(6). 589–594. 165 indexed citations

Azmi, Intan Diana Mat, Peter P. Wibroe, Linping Wu, et al.. (2016). A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies. Journal of Controlled Release. 239. 1–9. 81 indexed citations

Wibroe, Peter P., et al.. (2015). Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers. Nanomedicine Nanotechnology Biology and Medicine. 11(8). 1909–1914. 65 indexed citations

Wibroe, Peter P., Davoud Ahmadvand, Mohammad Ali Oghabian, Anan Yaghmur, & S. Moein Moghimi. (2015). An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome. Journal of Controlled Release. 221. 1–8. 153 indexed citations

Moghimi, S. Moein, Peter P. Wibroe, Linping Wu, & Z. Shadi Farhangrazi. (2015). Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system. Durham Research Online (Durham University). 7(3). 263–268. 7 indexed citations

Azmi, Intan Diana Mat, Linping Wu, Peter P. Wibroe, et al.. (2015). Modulatory Effect of Human Plasma on the Internal Nanostructure and Size Characteristics of Liquid-Crystalline Nanocarriers. Langmuir. 31(18). 5042–5049. 57 indexed citations

Wibroe, Peter P., Søren Petersen, N. Bovet, Bo W. Laursen, & S. Moein Moghimi. (2015). Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state. Biomaterials. 78. 20–26. 32 indexed citations

Wibroe, Peter P., et al.. (2014). The Role of Complement in Antibody Therapy for Infectious Diseases. Microbiology Spectrum. 2(2). 6 indexed citations

Khatchatouriants, Artium, Leonardo J. Solmesky, Peter P. Wibroe, et al.. (2013). Structural profiling and biological performance of phospholipid–hyaluronan functionalized single-walled carbon nanotubes. Journal of Controlled Release. 170(2). 295–305. 25 indexed citations

10.

Hunter, A. Christy, et al.. (2012). Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective. Maturitas. 73(1). 5–18. 35 indexed citations

11.

Moghimi, S. Moein, et al.. (2012). Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward. Advanced Drug Delivery Reviews. 64(13). 1385–1393. 38 indexed citations

12.

Hunter, A. Christy, et al.. (2012). Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine Nanotechnology Biology and Medicine. 8. S5–S20. 82 indexed citations

13.

Andersen, Alina J., Peter P. Wibroe, & S. Moein Moghimi. (2012). Perspectives on carbon nanotube-mediated adverse immune effects. Advanced Drug Delivery Reviews. 64(15). 1700–1705. 51 indexed citations

14.

Moghimi, S. Moein, Alina J. Andersen, Davoud Ahmadvand, et al.. (2011). Material properties in complement activation. Advanced Drug Delivery Reviews. 63(12). 1000–1007. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact